Skip to content Skip to footer
AbbVie Inc. (NYSE: ABBV) has secured (Sept. 28) FDA approval for JUVMO™ (tavapadon), a new once-daily Parkinson’s therapy, adding an important fresh option to a market long defined by the delicate art of managing motor symptoms, “OFF” time, dyskinesia and medication burden. For Serina…
NVIDIA Corp. (NASDAQ: NVDA) seemingly has given many a two-part bullish signal: a record-sized $150 billion increase to its share-repurchase authorization and a new AI-agent safety platform aimed at making autonomous software more secure for enterprise deployment. The combination suggests a company using…
Wall Street’s latest AI conversation is becoming less about clever chatbots and more about the decidedly unglamorous work of power, chips, networks, security and uptime. That shift may be constructive for investors: it broadens the AI opportunity from a small club of…
The energy market is developing a new hierarchy of importance: dependable power for artificial intelligence, domestic solar capacity insulated from fragile supply chains, and barrels that can reach market efficiently. Bloom Energy Corp. (NYSE: BE), First Solar, Inc. (NASDAQ: FSLR), T1 Energy Inc. (NYSE: TE) and Sable…